BR9814751A - Composição sólida seca para liberação de droga, processo para a preparação da mesma, e, uso de um grande número de partìculas porosas inorgânicas que são compostas de hidroxiapatita de cerâmica. - Google Patents
Composição sólida seca para liberação de droga, processo para a preparação da mesma, e, uso de um grande número de partìculas porosas inorgânicas que são compostas de hidroxiapatita de cerâmica.Info
- Publication number
- BR9814751A BR9814751A BR9814751-0A BR9814751A BR9814751A BR 9814751 A BR9814751 A BR 9814751A BR 9814751 A BR9814751 A BR 9814751A BR 9814751 A BR9814751 A BR 9814751A
- Authority
- BR
- Brazil
- Prior art keywords
- large number
- drug
- oily
- greasy
- solid composition
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 239000000919 ceramic Substances 0.000 title abstract 2
- 239000008247 solid mixture Substances 0.000 title abstract 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 title 1
- 239000010954 inorganic particle Substances 0.000 title 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 title 1
- 239000002245 particle Substances 0.000 abstract 3
- 239000000126 substance Substances 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMPOSIçãO SóLIDA SECA PARA LIBERAçãO DE DROGA, PROCESSO PARA A PREPARAçãO DA MESMA, E, USO DE UM GRANDE NúMERO DE PARTìCULAS POROSAS INORGâNICAS QUE SãO COMPOSTAS DE HIDROXIAPATITA DE CERâMICA". Um sistema para liberação de droga para administração oral em forma seca sólida de uma substância gordurosa / oleosa / pegajosa e de uma substância farmaceuticamente ativa que por si mesma é gordurosa / oleosa / pegajosa caracterizada por ter um grande número de partículas porosas inorgânicas de pequeno tamanho incorporadas a quantidades consideráveis de substâncias gordurosa / oleosas / pegajosas e que têm caraterísticas de liberação rápida e um processo para a preparação de tais partículas porosas inorgânicas que contenham substâncias gordurosas / oleosas / pegajosas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9704400A SE9704400D0 (sv) | 1997-11-28 | 1997-11-28 | Porous inorganic particles as carriers for drug substances |
PCT/SE1998/002089 WO1999027912A1 (en) | 1997-11-28 | 1998-11-19 | Porous hydroxyapatite particles as carriers for drug substances |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9814751A true BR9814751A (pt) | 2000-10-03 |
Family
ID=20409177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9814751-0A BR9814751A (pt) | 1997-11-28 | 1998-11-19 | Composição sólida seca para liberação de droga, processo para a preparação da mesma, e, uso de um grande número de partìculas porosas inorgânicas que são compostas de hidroxiapatita de cerâmica. |
Country Status (26)
Country | Link |
---|---|
US (1) | US6558703B1 (pt) |
EP (1) | EP1032370B1 (pt) |
JP (1) | JP2001524513A (pt) |
KR (1) | KR20010032557A (pt) |
CN (1) | CN1280492A (pt) |
AR (1) | AR016683A1 (pt) |
AT (1) | ATE256453T1 (pt) |
AU (1) | AU752044B2 (pt) |
BR (1) | BR9814751A (pt) |
CA (1) | CA2311780A1 (pt) |
DE (1) | DE69820674T2 (pt) |
DK (1) | DK1032370T3 (pt) |
ES (1) | ES2210840T3 (pt) |
HU (1) | HUP0100303A3 (pt) |
ID (1) | ID24700A (pt) |
IL (1) | IL136146A0 (pt) |
NO (1) | NO20002719L (pt) |
NZ (1) | NZ504353A (pt) |
PL (1) | PL340927A1 (pt) |
PT (1) | PT1032370E (pt) |
RU (1) | RU2219907C2 (pt) |
SE (1) | SE9704400D0 (pt) |
SK (1) | SK6602000A3 (pt) |
TW (1) | TW524694B (pt) |
WO (1) | WO1999027912A1 (pt) |
ZA (1) | ZA9810463B (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9924334D0 (en) * | 1999-10-15 | 1999-12-15 | Secr Defence | Pharmaceutical products and methods of fabrication therefor |
CZ301790B6 (cs) * | 2000-04-11 | 2010-06-23 | Sankyo Company Limited | Farmaceutický prípravek obsahující blokátor vápníku |
IT1319202B1 (it) | 2000-10-12 | 2003-09-26 | Nicox Sa | Farmaci per le malattie a base infiammatoria. |
US6462021B1 (en) | 2000-11-06 | 2002-10-08 | Astrazeneca Ab | Use of low molecular weight thrombin inhibitor |
WO2004050637A2 (en) | 2002-12-03 | 2004-06-17 | Axys Pharmaceuticals, Inc. | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
KR101207553B1 (ko) | 2005-06-02 | 2012-12-03 | (주)씨앤팜 | 금속 이중층 수산화물을 포함하는 생체 주사제용 약물 담체 |
TW200736245A (en) * | 2005-11-29 | 2007-10-01 | Sankyo Co | Acid addition salts of optically active dihydropyridine derivatives |
TW200806648A (en) * | 2005-11-29 | 2008-02-01 | Sankyo Co | Acid addition salts of dihydropyridine derivatives |
JP5027410B2 (ja) * | 2005-12-13 | 2012-09-19 | 株式会社サンギ | ユビキノン含有組成物 |
US8287914B2 (en) * | 2006-01-12 | 2012-10-16 | Rutgers, The State University Of New Jersey | Biomimetic hydroxyapatite synthesis |
US20100040668A1 (en) * | 2006-01-12 | 2010-02-18 | Rutgers, The State University Of New Jersey | Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof |
GB0909460D0 (en) | 2009-06-02 | 2009-07-15 | Intrinsiq Materials Global Ltd | Mesoporus material |
JP6513031B2 (ja) | 2013-02-01 | 2019-05-15 | ダブリュー・アール・グレース・アンド・カンパニー−コーンW R Grace & Co−Conn | 液体テクノロジーのための担体としての多孔質シリカゲル |
AU2014322985B2 (en) * | 2013-09-20 | 2019-05-16 | Tillotts Pharma Ag | Delayed release pharmaceutical formulation |
CN104133014B (zh) * | 2014-07-16 | 2015-09-16 | 广州法尔麦兰药物技术有限公司 | 一种考察布洛伪麻缓释制剂释放度的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8413191D0 (en) | 1984-05-23 | 1984-06-27 | Beecham Group Plc | Pharmaceutical composition |
GB8713263D0 (en) | 1987-06-05 | 1987-07-08 | Unilever Plc | Spheroidal silica |
US5055307A (en) | 1988-12-29 | 1991-10-08 | Asahi Kagaku Kogyo Kabushiki Kaisha | Slow release drug delivery granules and process for production thereof |
US5149523A (en) * | 1989-06-20 | 1992-09-22 | Aktiebolaget Hassle | Polystyrenesulfonate-drug complex and solid dosage forms thereof |
NL9100105A (nl) * | 1991-01-23 | 1992-08-17 | Kuil R A Holding | Voedingssupplement. |
US5443459A (en) * | 1991-01-30 | 1995-08-22 | Alza Corporation | Osmotic device for delayed delivery of agent |
US5834496A (en) * | 1991-12-02 | 1998-11-10 | Sepracor, Inc. | Methods for treating hypertension using optically pure S(-) felodipine |
US5947893A (en) * | 1994-04-27 | 1999-09-07 | Board Of Regents, The University Of Texas System | Method of making a porous prothesis with biodegradable coatings |
US6096324A (en) * | 1995-06-13 | 2000-08-01 | Laboratory Skin Care | Methods of delivering materials into the skin, and compositions used therein |
-
1997
- 1997-11-28 SE SE9704400A patent/SE9704400D0/xx unknown
-
1998
- 1998-10-27 TW TW087117781A patent/TW524694B/zh not_active IP Right Cessation
- 1998-11-16 ZA ZA9810463A patent/ZA9810463B/xx unknown
- 1998-11-16 AR ARP980105798A patent/AR016683A1/es not_active Application Discontinuation
- 1998-11-18 US US09/214,318 patent/US6558703B1/en not_active Expired - Fee Related
- 1998-11-19 AT AT98957268T patent/ATE256453T1/de not_active IP Right Cessation
- 1998-11-19 NZ NZ504353A patent/NZ504353A/en unknown
- 1998-11-19 PL PL98340927A patent/PL340927A1/xx unknown
- 1998-11-19 HU HU0100303A patent/HUP0100303A3/hu unknown
- 1998-11-19 EP EP98957268A patent/EP1032370B1/en not_active Expired - Lifetime
- 1998-11-19 KR KR1020007005802A patent/KR20010032557A/ko not_active Application Discontinuation
- 1998-11-19 AU AU13563/99A patent/AU752044B2/en not_active Ceased
- 1998-11-19 SK SK660-2000A patent/SK6602000A3/sk unknown
- 1998-11-19 IL IL13614698A patent/IL136146A0/xx unknown
- 1998-11-19 CA CA002311780A patent/CA2311780A1/en not_active Abandoned
- 1998-11-19 RU RU2000113731/15A patent/RU2219907C2/ru not_active IP Right Cessation
- 1998-11-19 ES ES98957268T patent/ES2210840T3/es not_active Expired - Lifetime
- 1998-11-19 JP JP2000522898A patent/JP2001524513A/ja active Pending
- 1998-11-19 ID IDW20000937A patent/ID24700A/id unknown
- 1998-11-19 DK DK98957268T patent/DK1032370T3/da active
- 1998-11-19 BR BR9814751-0A patent/BR9814751A/pt not_active IP Right Cessation
- 1998-11-19 PT PT98957268T patent/PT1032370E/pt unknown
- 1998-11-19 WO PCT/SE1998/002089 patent/WO1999027912A1/en not_active Application Discontinuation
- 1998-11-19 CN CN98811634A patent/CN1280492A/zh active Pending
- 1998-11-19 DE DE69820674T patent/DE69820674T2/de not_active Expired - Lifetime
-
2000
- 2000-05-26 NO NO20002719A patent/NO20002719L/no unknown
Also Published As
Publication number | Publication date |
---|---|
US6558703B1 (en) | 2003-05-06 |
AR016683A1 (es) | 2001-07-25 |
SK6602000A3 (en) | 2001-01-18 |
NZ504353A (en) | 2001-10-26 |
AU1356399A (en) | 1999-06-16 |
ATE256453T1 (de) | 2004-01-15 |
WO1999027912A1 (en) | 1999-06-10 |
RU2219907C2 (ru) | 2003-12-27 |
PL340927A1 (en) | 2001-03-12 |
EP1032370B1 (en) | 2003-12-17 |
HUP0100303A3 (en) | 2004-03-29 |
HUP0100303A2 (hu) | 2001-08-28 |
IL136146A0 (en) | 2001-05-20 |
SE9704400D0 (sv) | 1997-11-28 |
DK1032370T3 (da) | 2004-03-15 |
CN1280492A (zh) | 2001-01-17 |
DE69820674D1 (de) | 2004-01-29 |
TW524694B (en) | 2003-03-21 |
KR20010032557A (ko) | 2001-04-25 |
CA2311780A1 (en) | 1999-06-10 |
NO20002719L (no) | 2000-07-28 |
JP2001524513A (ja) | 2001-12-04 |
ID24700A (id) | 2000-08-03 |
AU752044B2 (en) | 2002-09-05 |
PT1032370E (pt) | 2004-05-31 |
DE69820674T2 (de) | 2004-09-30 |
EP1032370A1 (en) | 2000-09-06 |
ES2210840T3 (es) | 2004-07-01 |
NO20002719D0 (no) | 2000-05-26 |
ZA9810463B (en) | 1999-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9814751A (pt) | Composição sólida seca para liberação de droga, processo para a preparação da mesma, e, uso de um grande número de partìculas porosas inorgânicas que são compostas de hidroxiapatita de cerâmica. | |
BR9814756A (pt) | Composição sólida seca para liberação de droga, processo para a preparação da mesma, uso de um grande número de pequenas esferas que contêm uma matriz polimérica composta de um polietileno glicol ou de uma mistura de polietileno glicóis | |
BR9811249A (pt) | Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma | |
BRPI0015567B8 (pt) | composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica | |
DE69931930D1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen | |
ID23806A (id) | Komposisi-komposisi farmasi untuk pemberian oral yang terdiri dari bahan aktif dan siklodekstrin | |
ES2181055T3 (es) | Formulaciones galenicas que contienen antagonistas de opiaceos. | |
PT1087750E (pt) | Formulacoes farmaceuticas para aerossois com duas ou mais substancias activas | |
PT1283700E (pt) | Composicoes farmaceuticas de libertacao prolongada destinadas a administracao por via parental de compostos hidrofilos biologicamente activos | |
ES2052016T3 (es) | Composicion emulsionada. | |
BR9808933A (pt) | Composição sob forma de microcápsulas ou de implantes, processo de preparação de uma substância hidrossolúvel, substância ativa, acetato de triptorelina, acetato de lanreotìdeo, ou acetato de octreotìdeo, e rna de filamento duplo | |
DK1183014T3 (da) | Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse | |
CA2346001A1 (en) | Controlled release nanoparticulate compositions | |
BR9913945A (pt) | Composição farmacêutica para o tratamento de distúrbios agudos por meio de administração sublingual, e, processo para o tratamento de distúrbios agudos | |
IT1251153B (it) | Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica | |
BR9808703A (pt) | Composição que fornece medicamento solúvel emágua de dissolução relativamente lenta e usosublingual | |
DE60024414T2 (de) | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen | |
DE69716469T2 (de) | Pharmazeutische zusammensetzung enthaltend ein osteogenese foerderndes mittel und ein polyethylen-glycol | |
RS50298B (sr) | Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina | |
BR9811458A (pt) | "sistema solvente para penetração melhorada de compostos farmacêuticos" | |
RU2000113731A (ru) | Пористые частицы гидроксиапатита в качестве носителей для лекарственных веществ | |
JP2001524513A5 (pt) | ||
PT994887E (pt) | Glicosidos modificados composicoes que compreendem os mesmos e metodos para a sua utilizacao | |
AR021845A1 (es) | Derivados de 1,3-diaril-2-piridin-2-il-3-(piridin-2-ilamino)-propanol sustituidos, composiciones farmaceuticas y medicamentos que las comprenden, procedimientos para su preparacion, medicamentos que contienen estos compuestos, y su utilizacion para la preparcion de medicamentos | |
EE04194B1 (et) | Pentasahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7O E 8O ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007. |